Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2/3 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 159INDUSTRY 32NIH 6OTHER_GOV 3NETWORK 2INDIV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1

Conditions

Spondylitis, Ankylosing 1Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 49Capecitabine 42Radiotherapy 33Oxaliplatin 33Gemcitabine 33apatinib 32Cyclophosphamide 32Drug Therapy 31Paclitaxel 30Carboplatin 29tislelizumab 27Irinotecan 27Fluorouracil 26Docetaxel 26Bevacizumab 23Surgical Procedures, Operative 20Nivolumab 19pembrolizumab 18fludarabine 18Metformin 16Exercise 16Radiation 15camrelizumab 14S 1 (combination) 14Control Groups 14Blood Specimen Collection 14Pemetrexed 13Standard of Care 12anlotinib 11Neoadjuvant Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Sodium Chloride × Clear all
NCT04741880 2021-07-30

ELSA

Instituto Nacional de Cancer, Brazil

Phase 2/3 Unknown
66 enrolled
Tumor-Agnostic

Neoplasms

NCT02313727 2014-12-10

Combined Treatment With TNF Inhibitor and Pamidronate in AS Patients: Effect on the Radiographic Progression

Bnai Zion Medical Center

Phase 4 Unknown
30 enrolled

Spondylitis, Ankylosing

NCT01836575 2013-04-22

PS2

Instituto Nacional de Cancer, Brazil

Phase 3 Completed
228 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡